Purchase Order 75N94020P00517
- Not listed
- The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded an $11,552 firm fixed price purchase order to The Regents of the University of California, San Francisco for prospective studies of telomere length dynamics and their relationship to type 2 diabetes outcomes as part of a larger research effort. The University of California, San Francisco will serve as the prime contractor, delivering research services over the eleven-month period of...
- <p>The National Institute of Child Health and Human Development awarded a purchase order to The Regents of the University of California, San Francisco for a telomere length assay supporting a five-year study, with a ceiling value of $16,744.00 and an award date of June 29, 2021. Work is performed in San Francisco, California. The purchase order carries a firm fixed price and is scheduled for completion on July 29, 2027.</p>
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, awarded a $4,718,238.42 definitive cost-no-fee contract to the University of California, San Diego (UCSD) to conduct a Diabetic Complications Study. The contract, which does not have a set-aside designation, was awarded on May 1, 2006 with a completion date of December 31, 2012. UCSD, a leading public research university, is known for its expertise in areas such as cognitive science, computer...
- This federal contract award is for biomedical research and services, with a total ceiling value of $10,607,389.80. The contract was awarded on March 28, 1996 to the prime contractor, The Regents of the University of California, San Francisco (UCSF), and has an ultimate completion date of February 14, 2013. The contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract is a definitive...
- <p>The National Institute of Child Health and Human Development awarded a firm fixed price purchase order to The Regents of the University of California, San Francisco (UCSF) for $22,448.00 on April 30, 2021, for genome core gene expression profiling services. Performance will occur in San Francisco, California, with completion scheduled for September 30, 2021. The work is part of UCSF's Genomics Colab and supports hypothesis-driven biomedical research capabilities.</p>
- This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the University of California, Los Angeles (UCLA) for $18,702.14 on a Firm Fixed Price basis. The contract, which has no set-aside designation, was awarded on August 16, 2018 with a completion date of January 31, 2019. UCLA is registered in the System for Award Management (SAM.gov) as a U.S. state government entity, specifically an 1862 Land Grant College...
- This is a $65,800 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a for-profit limited liability company based in Ottawa, Canada. The contract is for laboratory services to perform telomere length measurement using a 6-panel flow fluorescence in situ hybridization (flow-FISH) assay. This contract supports NCI's research into the correlation between telomere length and...
- This federal contract award, valued at $3,996,255.00, was issued by the National Institute on Aging to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The contract, which is not set aside, aims to identify genetic risk factors for Alzheimer's Disease (AD) and Frontotemporal Dementia (FTD) in diverse populations across Latin America. UCSF has collaborated with several Latin American institutions, including Fundacao...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Cosmo Bio USA Inc. for $32,936.00 on August 22, 2019. Work is performed in Carlsbad, California. The order is priced on a firm fixed price basis with an ultimate completion date of February 24, 2020. The originating pre-solicitation opportunity was posted July 28, 2019 with an August 6, 2019 due date.</p>
- <p>The National Cancer Institute issued a delivery order to Repeat Diagnostics Inc. on December 18, 2015, with a ceiling value of $4,450.00 for laboratory testing services of telomere length assays supporting the Inherited Bone Marrow Failure Study.</p> <p>Place of performance is Rockville, Maryland. The order was firm fixed price with an ultimate completion date of May 26, 2021. The award involved de-obligation of funds from expiring FY2016 lines and was issued under no set-aside.</p>
This federal contract award, with ID 75N94020P00517, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to The Regents of the University of California, San Francisco (UCSF) for a firm fixed-price purchase order valued at $90,560.00. The contract is to acquire telomere length measurements in peripheral blood samples from participants in the Diabetes Epidemiology and Clinical Research Section (DECRS) studies, in order to analyze the relationship between telomere length and the development of type 2 diabetes. The contract was awarded without a set-aside and has an ultimate completion date of July 31, 2021. UCSF was selected as the sole-source provider for this work, as their laboratory has previously conducted telomere length assays on a subset of the DECRS samples, allowing for combined analysis of the data.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Prospective Study of Telomere Length Dynamics & Type 2 Diabetes Related Outcomes | NICHD-20-151 | Department of Health and Human Services National Institutes of Health | Pre-Solicitation 1/1 | 7/12/20, 11:28 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $90.6k | 7/20/20 |